{"schema_version":"secwatch.filing_event.v1","accession":"0001823239-22-000042","form_type":"8-K","ticker":"MRVI","cik":"0001823239","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.244959+00:00","generated_at":"2026-06-24T04:27:35.956131+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"medium","headline":"Maravai Q2 revenue $242.7M (+11% YoY), net income $156.7M (+17%), Adj. EBITDA margin 78% record","bullets":["Q2 revenue $242.7M (+11% YoY); net income $156.7M (+17%); Adj. EBITDA $188.5M (78% margin).","Nucleic Acid Production revenue $225.2M (+17% YoY); base business (ex-COVID CleanCap) grew 27%.","Biologics Safety Testing revenue $17.5M (-4% YoY); Protein Detection business sold in Sept 2021.","Leadership additions: Pete Leddy as EVP/CAO, Kate Broderick SVP R&D, Jay Lochhead VP Quality & Regulatory.","Signed DoD cooperative agreement to partly fund Nucleic Acid Production manufacturing expansion in San Diego."],"urls":{"canonical":"https://secwatch.observer/filing/0001823239-22-000042","json":"https://secwatch.observer/filing/0001823239-22-000042.json","markdown":"https://secwatch.observer/filing/0001823239-22-000042.md","text":"https://secwatch.observer/filing/0001823239-22-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000042/0001823239-22-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000042/mrvi-20220804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:27:35.956131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}